MedTrace Logo

COPD and Cardiovascular Risk in the Population

NCT00787748 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 623

Last updated 2012-06-15

No results posted yet for this study

Summary

The prevalence of chronic obstructive pulmonary disease (COPD) in patients with cardiovascular disease (CVD) is unknown, and whether or not COPD is adequately diagnosed and treated in these patients has not been investigated before.

We hypothesized that the prevalence of COPD would be significantly higher (30%) in patients with CVD than in the general population. Besides, we anticipated that COPD, a potentially treatable CV risk factor, would be undiagnosed in more than 80% of CVD patients.

Conditions

Sponsors & Collaborators

  • Fondo de Investigacion Sanitaria

    collaborator OTHER

  • Cimera

    lead NETWORK

Principal Investigators

  • Fernando Rigo, MD · Atención Primaria de Mallorca

  • Alvar Agusti, MD · Cimera

Eligibility

Min Age
40 Years
Max Age
81 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-10-31
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • Spain

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00787748 on ClinicalTrials.gov